Case and Research Letter
Risk of hepatitis B virus reactivation in patients treated with anti-TNFα agents for immune-mediated inflammatory diseases
Riesgo de reactivación de la hepatitis B en los pacientes tratados con agentes anti-TNFα para enfermedades inflamatorias inmuno-mediadas
Leído
6665
Vecesse ha leído el artículo
2316
Total PDF
4349
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 11 | 13 | 2 | 15 |
| 2025 10 | 114 | 33 | 147 |
| 2025 9 | 88 | 34 | 122 |
| 2025 8 | 60 | 28 | 88 |
| 2025 7 | 103 | 28 | 131 |
| 2025 6 | 114 | 45 | 159 |
| 2025 5 | 244 | 38 | 282 |
| 2025 4 | 141 | 25 | 166 |
| 2025 3 | 231 | 24 | 255 |
| 2025 2 | 130 | 27 | 157 |
| 2025 1 | 77 | 26 | 103 |
| 2024 12 | 71 | 21 | 92 |
| 2024 11 | 74 | 50 | 124 |
| 2024 10 | 59 | 42 | 101 |
| 2024 9 | 67 | 30 | 97 |
| 2024 8 | 79 | 58 | 137 |
| 2024 7 | 107 | 32 | 139 |
| 2024 6 | 79 | 38 | 117 |
| 2024 5 | 63 | 28 | 91 |
| 2024 4 | 73 | 22 | 95 |
| 2024 3 | 61 | 19 | 80 |
| 2024 2 | 56 | 23 | 79 |
| 2024 1 | 57 | 23 | 80 |
| 2023 12 | 61 | 33 | 94 |
| 2023 11 | 90 | 48 | 138 |
| 2023 10 | 78 | 28 | 106 |
| 2023 9 | 85 | 26 | 111 |
| 2023 8 | 69 | 11 | 80 |
| 2023 7 | 65 | 21 | 86 |
| 2023 6 | 49 | 20 | 69 |
| 2023 5 | 74 | 25 | 99 |
| 2023 4 | 61 | 17 | 78 |
| 2023 3 | 98 | 28 | 126 |
| 2023 2 | 58 | 44 | 102 |
| 2022 1 | 38 | 49 | 87 |
| 2022 12 | 57 | 45 | 102 |
| 2022 11 | 48 | 41 | 89 |
| 2022 10 | 52 | 40 | 92 |
| 2022 9 | 46 | 44 | 90 |
| 2022 8 | 44 | 42 | 86 |
| 2022 7 | 38 | 46 | 84 |
| 2022 6 | 34 | 30 | 64 |
| 2022 5 | 31 | 44 | 75 |
| 2022 4 | 46 | 30 | 76 |
| 2022 3 | 42 | 52 | 94 |
| 2022 2 | 35 | 19 | 54 |
| 2021 1 | 37 | 35 | 72 |
| 2021 12 | 42 | 41 | 83 |
| 2021 11 | 30 | 40 | 70 |
| 2021 10 | 40 | 55 | 95 |
| 2021 9 | 36 | 40 | 76 |
| 2021 8 | 26 | 31 | 57 |
| 2021 7 | 21 | 36 | 57 |
| 2021 6 | 37 | 34 | 71 |
| 2021 5 | 29 | 27 | 56 |
| 2021 4 | 71 | 54 | 125 |
| 2021 3 | 46 | 22 | 68 |
| 2021 2 | 68 | 29 | 97 |
| 2020 1 | 40 | 28 | 68 |
| 2020 12 | 34 | 20 | 54 |
| 2020 11 | 19 | 27 | 46 |
| 2020 10 | 23 | 24 | 47 |
| 2020 9 | 41 | 24 | 65 |
| 2020 8 | 25 | 29 | 54 |
| 2020 7 | 17 | 22 | 39 |
| 2020 6 | 43 | 40 | 83 |
| 2020 5 | 27 | 40 | 67 |
| 2020 4 | 39 | 28 | 67 |
| 2020 3 | 24 | 32 | 56 |
| 2020 1 | 4 | 0 | 4 |
| 2019 12 | 4 | 0 | 4 |
| 2019 11 | 4 | 0 | 4 |
| 2019 9 | 4 | 0 | 4 |
| 2019 8 | 4 | 0 | 4 |
| 2019 7 | 4 | 0 | 4 |
| 2019 6 | 3 | 0 | 3 |
| 2019 5 | 5 | 0 | 5 |
| 2019 4 | 2 | 0 | 2 |
| 2019 2 | 2 | 0 | 2 |
| 2018 12 | 2 | 4 | 6 |
| 2018 11 | 9 | 4 | 13 |
| 2018 10 | 2 | 0 | 2 |
| 2018 9 | 1 | 0 | 1 |
| 2018 7 | 1 | 0 | 1 |
| 2018 6 | 1 | 0 | 1 |
| 2018 5 | 2 | 2 | 4 |
| 2018 4 | 20 | 10 | 30 |
| 2018 2 | 0 | 11 | 11 |
| 2018 1 | 0 | 8 | 8 |
| 2017 12 | 0 | 12 | 12 |
| 2017 11 | 0 | 12 | 12 |
| 2017 10 | 0 | 16 | 16 |
Mostrar todo
